Application of Intracavity Electrocardiogram Positioning Technique in PICC

Sponsor
Shandong Branden Med.Device Co.,Ltd (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05555160
Collaborator
Third Affiliated Hospital, Sun Yat-Sen University (Other)
3,051
2
15

Study Details

Study Description

Brief Summary

This study was a prospective, multicenter, randomized controlled study. The study aimed to exploring the influence of PICC intra catheter guide wire or PICC conductive tip as intra luminal electrode on the positioning accuracy of catheter tip and exploring the influence of PICC intra catheter guide wire or PICC conductive tip as intra luminal electrode on catheterization complications.

Condition or Disease Intervention/Treatment Phase
  • Device: PICC
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3051 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Application of Intracavity Electrocardiogram Positioning Technique in Catheterization of Valvular PICC
Anticipated Study Start Date :
Sep 30, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Single-chamber valve tip conductive PICC catheter

Device: PICC
Peripheral central venous catheterization (PICC) is mainly applied to patients with medium and long-term intravenous infusion, infusion of stimulant drugs and intermittent infusion of chemotherapy drugs. It is a catheterization technology to place PICC through peripheral veins and make its tip reach the central vein

Experimental: Single - chamber valve non - tip conductive PICC catheter

Device: PICC
Peripheral central venous catheterization (PICC) is mainly applied to patients with medium and long-term intravenous infusion, infusion of stimulant drugs and intermittent infusion of chemotherapy drugs. It is a catheterization technology to place PICC through peripheral veins and make its tip reach the central vein

Outcome Measures

Primary Outcome Measures

  1. Accuracy of tip determination [Immediately after surgery]

    IC-ECG method was used to place the tube, and X-ray was used to determine the accuracy of tip location after confirmation. If the two judgments are inconsistent, the third method, such as echocardiography, shall be used. The tip determination accuracy of IC-ECG localization method and X-ray localization method were calculated respectively.X-ray judgment standard: the reference standard is the first choice of the cardiac shadow method: not exceeding the highest protrusion on the left side of the cardiac shadow (tracheal protrusion method: 0-3cm below the tracheal protrusion); Secondary rib reading method: posterior 5-7 ribs.

Secondary Outcome Measures

  1. incidence of PICC-related complications [After the operation to 180 days]

    Complications related to puncture and catheter during tube placement and retention include redness and swelling, bleeding, exudation, puncture point infection, ectopic catheter, displacement, catheter blockage, rupture, phlebitis and thrombosis.

  2. success rate of one catheterization [Immediately after surgery]

    one-time successful catheterization means that the tip of the catheter can be placed at the ideal position in one catheterization operation, without adjustment after X-ray confirmation. After catheterization, both groups of patients need to verify whether the tip is in the ideal position through X-ray, and whether the operation is successful also needs to be judged through X-ray, and the X-ray results need to be retained (random number, center code, initials, time). All results will be sent to the central laboratory for analysis and interpretation.

  3. rate of convenient [Immediately after surgery]

    survey whether the operators think the operation is convenient through questionnaires made by ourselves.

  4. rate of unplanned extubation [After the operation to 180 days]

    Proportion of early removal due to complications

  5. Retention duration [After the operation to 180 days]

  6. Medical costs resulting from complications [After the operation to 180 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients ≥18 years old who need PICC catheterization for the first time according to the doctor's advice;

  • No serious cardiovascular diseases before catheterization, such as atrial fibrillation, pulmonary heart disease and other P wave abnormalities, serious heart block, etc.;

  • patients who did not participate in other clinical studies;

  • Patients who voluntarily participated in the clinical study, signed informed consent and cooperated with clinical follow-up

Exclusion Criteria:
  • patients with local malformation or scar formation;

  • Patients with infection or damage at the puncture site;

  • patients with tumor compression of blood vessels;

  • Patients with confirmed or suspected catheter-related infection, bacteremia and septicemia

  • Patients diagnosed or suspected to be allergic to silicone material

  • Patients with a history of radiotherapy at the pre-intubation site

  • Patients with a history of venous thrombosis, trauma or vascular surgery

  • Patients with superior vena cava syndrome

  • Patients with poor medical behavior

  • Patients with severe peripheral vascular edema

  • High-flow fluid infusion, patients requiring hemodialysis, pacemaker installation, crutches, or patients who may undergo A-V fistula

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Shandong Branden Med.Device Co.,Ltd
  • Third Affiliated Hospital, Sun Yat-Sen University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shandong Branden Med.Device Co.,Ltd
ClinicalTrials.gov Identifier:
NCT05555160
Other Study ID Numbers:
  • B-202103
First Posted:
Sep 26, 2022
Last Update Posted:
Sep 26, 2022
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 26, 2022